Acutaas Chemicals Posts Robust Annual Growth Despite Quarterly Slowdown
Revenue and profit soared over 59% and 70% year-on-year, but declined sharply from the previous quarter's peak.
Acutaas Chemicals delivered impressive year-on-year growth in Q1 FY27, though results softened from the record highs of Q4 FY26. The net profit margin improved annually but retreated from last quarter.
Acutaas Chemicals kicked off FY27 with powerful year-on-year growth, but momentum eased from the previous quarter's high. Revenue for Q1 FY27 jumped 59.1% to ₹329.68 crore compared to the same period last year, while profit surged an even stronger 70.4% to ₹74.99 crore. This performance lifted the net profit margin by 150 basis points to 22.7% on a yearly basis, signaling improved profitability.
However, the quarter-on-quarter comparison tells a different story. Both revenue and profit declined significantly from the record levels set in Q4 FY26, falling 23.8% and 44.2% respectively. This pulled the net profit margin down from 31.0% in the March quarter. The recent trajectory shows the company's performance remains well above levels from a year ago, but has moderated from its recent peak.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Period Ended | June 2026 | March 2026 | June 2025 |
| Revenue (₹ Cr) | 329.68YoY +59% | 432.75 | 207.24 |
| Profit (₹ Cr) | 74.99YoY +70% | 134.28 | 44.01 |
| Net Profit Margin (%) | 22.7YoY +7.1% | 31.0 | 21.2 |
Key Points
- The trailing twelve-month (TTM) net profit margin stands at a healthy 26.5%, with TTM profit at ₹387.35 crore.
- The company maintains a robust balance sheet with minimal debt (Debt-to-Equity of 0.01) and strong interest coverage of 35.76 times.
- The stock has delivered a remarkable 144.6% return over the past year, closing at ₹3,282.80 on the results date.
While the quarterly dip is notable, the underlying annual growth story remains intact, supported by a solid financial foundation. The key question for the coming quarters is whether the company can stabilize near these new, higher plateaus of revenue and profit.
Live Chart
· ACUTAAS
(BSE)
ISIN: INE00FF01025
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.